Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

被引：0
|
作者：
Hu, Bei [1 ]
Korsos, Victoria [2 ]
Palomba, M. Lia [2 ,3 ]
机构：
[1] Wake Forest Sch Med, Atrium Hlth Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC 28202 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
chimeric antigen receptor T cell therapy (CAR T cell therapy); diffuse large B cell lymphoma (DLBCL); high grade B cell lymphoma; mantle cell lymphoma (MCL); relapsed and refractory lymphoma; CENTRAL-NERVOUS-SYSTEM; AXICABTAGENE CILOLEUCEL; COST-EFFECTIVENESS; BREXUCABTAGENE AUTOLEUCEL; PREDICTIVE FACTORS; OUTCOMES; MULTICENTER; INFLAMMATION; PERSISTENCE; IBRUTINIB;
D O I：
10.3389/fonc.2024.1394057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell lymphoma and mantle cell lymphoma, highlighting their efficacy and toxicity as well as discussing future directions.
引用
收藏
页数：13
相关论文
共 50 条
  • [21] Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
    Wright, Christopher M.
    LaRiviere, Michael J.
    Baron, Jonathan A.
    Uche, Chibueze
    Xiao, Ying
    Arscott, W. Tristram
    Anstadt, Emily J.
    Barsky, Andrew R.
    Miller, David
    LaRose, Meredith, I
    Landsburg, Daniel J.
    Svoboda, Jakub
    Nasta, Sunita D.
    Gerson, James N.
    Barta, Stefan K.
    Chong, Elise A.
    Schuster, Stephen J.
    Paydar, Ima
    Maity, Amit
    Plastaras, John P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (01): : 178 - 188
  • [22] CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN ADULT PATIENTS WITH B-CELL LYMPHOPROLIFERATIVE DISEASES
    Gavrilina, O. A.
    Galstyan, G. M.
    Shchekina, A. E.
    Kotova, E. S.
    Maschan, M. A.
    Troitskaya, V. V.
    Koroleva, D. A.
    Zvonkov, E. E.
    Fidarova, Z. T.
    Vasilyeva, V. A.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (01): : 8 - 28
  • [23] Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell Lymphoma
    Mulholland, Nicola
    Chandra, Julie
    Sanderson, Robin
    Kuhnl, Andrea
    RADIOLOGY, 2023, 307 (05)
  • [24] Healthcare Utilization and Costs in Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Denlinger, Nathan
    Huang, Ying
    Braunstein, Zachary
    Sigmund, Audrey
    Bajwa, Amneet
    Kapoor, Nilesh
    Agyeman, Akwasi
    Fisher, Scott
    Purdin, Zebulun
    Neal, Alison
    Yucebay, Filiz
    Roddy, Julianna
    Brammer, Jonathan
    William, Basem
    Saad, Ayman
    Penza, Sam
    Voorhees, Timothy
    Kittai, Adam
    de Lima, Marcos
    Vasu, Sumithira
    Jaglowski, Samantha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S381 - S382
  • [25] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [26] Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
    Salem, Dalia A.
    Maric, Irina
    Yuan, Constance M.
    Liewehr, David J.
    Venzon, David J.
    Kochenderfer, James
    Stetler-Stevenson, Maryalice
    LEUKEMIA RESEARCH, 2018, 71 : 106 - 111
  • [27] New drugs for aggressive B-cell and T-cell lymphomas
    Murawski, Niels
    Pfreundschuh, Michael
    LANCET ONCOLOGY, 2010, 11 (11): : 1074 - 1085
  • [28] Radiation Prior to Chimeric Antigen Receptor T-Cell Therapy Is an Optimizing Bridging Strategy in Relapse/Refractory Aggressive B-Cell Lymphoma
    Yu, Qiuxia
    Zhang, Xiaoying
    Wang, Na
    Huang, Liang
    Li, Chunrui
    Zhang, Yicheng
    Zhou, Jianfeng
    Wang, Gaoxiang
    Cao, Yang
    BLOOD, 2022, 140 : 10311 - 10312
  • [29] Radiation prior to chimeric antigen receptor T-cell therapy is an optimizing bridging strategy in relapsed/refractory aggressive B-cell lymphoma
    Yu, Qiuxia
    Zhang, Xiaoying
    Wang, Na
    Li, Chunrui
    Zhang, Yicheng
    Zhou, Jianfeng
    Wang, Gaoxiang
    Cao, Yang
    RADIOTHERAPY AND ONCOLOGY, 2022, 177 : 53 - 60
  • [30] Chimeric antigen receptor T-cell therapy
    Burge, Cale
    Vanguru, Vinay
    Ho, Phoebe Joy
    AUSTRALIAN PRESCRIBER, 2023, 46 (02) : 36 - 39
12345